AbCellera Biologics Inc vs Invesco DB Oil Fund — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while Invesco DB Oil Fund trades at $21.06. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Invesco DB Oil Fund nearer its low. Which is the better fit depends on your goals.
| ABCL | DBO | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Commodities - Energy |
52-Week High | $9.76 | $23.80 |
52-Week Low | $2.78 | $11.98 |
Enterprise Value | $2.58B | — |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →